美国议员要求政府问责局审查 TrumpRx 药品节省宣称
STAT+: Lawmaker wants government watchdog to probe TrumpRx over claims about drug savings
美国众议院能源和商业委员会资深成员 Frank Pallone 致信政府问责局，要求审查 TrumpRx 平台是否真的为美国人节省了开支。白宫称该平台自 2 月上线以来已帮助美国人节省 7 亿美元，但 Pallone 指出政府未披露用于评估其财务效益的关键信息，尤其是与二十多家药企达成的最惠国协议细节。TrumpRx 本身不销售或分发药品，仅向消费者提供优惠券或折扣链接。
By Ed Silverman
Oct. 28, 2026
Pharmalot Columnist, Senior Writer
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.
A House lawmaker asked the Government Accountability Office to review whether the TrumpRx platform has saved Americans any money.
In an Oct. 27 letter, Frank Pallone (D-N.J.), the ranking member of the House Committee on Energy and Commerce, said the White House has made “sweeping statements” that the website has helped Americans save $700 million since it was launched in February. TrumpRx does not sell or dispense drugs but directs consumers to coupons or links for discounts.
However, Pallone said the Trump administration has failed to “disclose key information” that would help evaluate whether the platform has provided “any meaningful financial benefit,” he wrote. In particular, he cited the lack of details about most-favored nation agreements the White House reached with more than two dozen drugmakers.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源：STAT News · statnews.com